Subscribe & Follow
Advertise your job vacancies
Jobs
- Sales Consultant Bellville
- Insurance Sales Agent Mbekweni
- Key Account Manager George
- Graphic Designer Vereeniging
- Key Account Manager Johannesburg
- Sales Agent Paarl
- General Manager Johannesburg
- Sales Associate Paarl
- Sales Representative Paarl
- Business Development Manager Johannesburg
Nestlé to acquire biopharmaceutical company Aimmune
Nestlé Health Science (NHSc) is to acquire Aimmune Therapeutics in accordance with a definitive agreement between Nestlé and the biopharmaceutical company.
NHSc currently has a total investment in Aimmune of $473m, an approximate 25.6% equity ownership stake. The company made its initial investment of $145m in Aimmune in November 2016, followed by further investments of $30m in February 2018, $98m in November 2018 and $200m in January 2020.